Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1965 1
1969 1
1970 1
1971 1
1974 2
1975 3
1976 3
1977 2
1978 1
1979 2
1980 7
1981 3
1982 5
1983 6
1984 14
1985 13
1986 11
1987 9
1988 16
1989 12
1990 31
1991 28
1992 39
1993 45
1994 40
1995 45
1996 78
1997 63
1998 84
1999 107
2000 77
2001 87
2002 78
2003 98
2004 102
2005 144
2006 138
2007 165
2008 167
2009 207
2010 215
2011 230
2012 299
2013 281
2014 361
2015 366
2016 400
2017 445
2018 440
2019 472
2020 519
2021 434
2022 372
2023 323
2024 96

Text availability

Article attribute

Article type

Publication date

Search Results

6,359 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Metastatic Malignant Pancreatic Neoplasm"
Page 1
Pancreatic Cancer: A Review.
Park W, Chawla A, O'Reilly EM. Park W, et al. JAMA. 2021 Sep 7;326(9):851-862. doi: 10.1001/jama.2021.13027. JAMA. 2021. PMID: 34547082 Free PMC article. Review.
IMPORTANCE: Pancreatic ductal adenocarcinoma (PDAC) is a relatively uncommon cancer, with approximately 60 430 new diagnoses expected in 2021 in the US. ...OBSERVATIONS: Effective screening is not available for PDAC, and most patients present with locally advanced (30%-35% …
IMPORTANCE: Pancreatic ductal adenocarcinoma (PDAC) is a relatively uncommon cancer, with approximately 60 430 new diagnoses expected …
Pancreatic neuroendocrine tumors.
Perri G, Prakash LR, Katz MHG. Perri G, et al. Curr Opin Gastroenterol. 2019 Sep;35(5):468-477. doi: 10.1097/MOG.0000000000000571. Curr Opin Gastroenterol. 2019. PMID: 31306159 Review.
PURPOSE OF REVIEW: Pancreatic neuroendocrine tumors (pNETs) are a rare, heterogeneous group of pancreatic neoplasms with a wide range of malignant potential. ...RECENT FINDINGS: In recent years, because of the increasing amount of scientific literature …
PURPOSE OF REVIEW: Pancreatic neuroendocrine tumors (pNETs) are a rare, heterogeneous group of pancreatic neoplasms wit …
Pancreatic cancer and associated exosomes.
Zhao C, Gao F, Weng S, Liu Q. Zhao C, et al. Cancer Biomark. 2017 Dec 6;20(4):357-367. doi: 10.3233/CBM-170258. Cancer Biomark. 2017. PMID: 29036786 Review.
Pancreatic cancers with poor prognosis are highly malignant, readily metastatic and of immune tolerance, mainly due to delayed detection. The metastatic progression and immune tolerance of pancreatic cancer is greatly attributed to the in …
Pancreatic cancers with poor prognosis are highly malignant, readily metastatic and of immune tolerance, mainly …
Understanding the increasing incidence of neuroendocrine tumors.
Pathak S, Starr JS, Halfdanarson T, Sonbol MB. Pathak S, et al. Expert Rev Endocrinol Metab. 2023 Sep-Nov;18(5):377-385. doi: 10.1080/17446651.2023.2237593. Epub 2023 Jul 19. Expert Rev Endocrinol Metab. 2023. PMID: 37466336 Review.
INTRODUCTION: Neuroendocrine tumors (NETs) are a diverse group of tumors with origins from different primary sites such as gastro-entero-pancreatic, lung and endocrine tissue. Worldwide, their incidence has increased in recent decades. ...Although multiple genetics and env …
INTRODUCTION: Neuroendocrine tumors (NETs) are a diverse group of tumors with origins from different primary sites such as gastro-entero- …
Pancreatic cancer.
Cohen SJ, Pinover WH, Watson JC, Meropol NJ. Cohen SJ, et al. Curr Treat Options Oncol. 2000 Dec;1(5):375-86. doi: 10.1007/s11864-000-0065-2. Curr Treat Options Oncol. 2000. PMID: 12057145 Review.
Optimal therapy for pancreatic adenocarcinoma requires surgical removal with tumor-free margins. ...Gemcitabine can provide symptom relief and a modest improvement in survival for patients with metastatic disease. Strict attention to relief of symptoms such as pain, …
Optimal therapy for pancreatic adenocarcinoma requires surgical removal with tumor-free margins. ...Gemcitabine can provide symptom r …
Could the burden of pancreatic cancer originate in childhood?
Diaconescu S, Gîlcă-Blanariu GE, Poamaneagra S, Marginean O, Paduraru G, Stefanescu G. Diaconescu S, et al. World J Gastroenterol. 2021 Aug 28;27(32):5322-5340. doi: 10.3748/wjg.v27.i32.5322. World J Gastroenterol. 2021. PMID: 34539135 Free PMC article. Review.
However, there are primary malignant pancreatic tumors encountered in pediatric patients, such as pancreatoblastoma, and tumors considered benign in general but may present a malignant potential, such as the solid pseudo-papillary tumor, insulinoma, gastrinom …
However, there are primary malignant pancreatic tumors encountered in pediatric patients, such as pancreatoblastoma, and tumor …
Malignant Insulinoma: A Rare Form of Neuroendocrine Tumor.
Sada A, Glasgow AE, Vella A, Thompson GB, McKenzie TJ, Habermann EB. Sada A, et al. World J Surg. 2020 Jul;44(7):2288-2294. doi: 10.1007/s00268-020-05445-x. World J Surg. 2020. PMID: 32128613 Free PMC article. Review.
METHODS: We identified all patients with malignant insulinoma in the SEER registries from 1973 to 2015. Incidence, neoplasm characteristics and factors affecting cancer-specific survival (CSS) were described. ...The largest proportion had localized disease (40%), wh …
METHODS: We identified all patients with malignant insulinoma in the SEER registries from 1973 to 2015. Incidence, neoplasm ch …
Diabetes and pancreatic cancer.
De Souza AL, Saif MW. De Souza AL, et al. JOP. 2014 Mar 10;15(2):118-20. doi: 10.6092/1590-8577/2286. JOP. 2014. PMID: 24618432 Free article.
CONTEXT: Pancreatic cancer is the fourth leading cause of cancer mortality in the United States. ...Biomarkers for early diagnosis of pancreatic cancer among diabetic patients and metformin as a biologic therapy for pancreatic cancer are herein discussed. ...
CONTEXT: Pancreatic cancer is the fourth leading cause of cancer mortality in the United States. ...Biomarkers for early diagnosis of …
Nonfunctional pancreatic neuroendocrine tumors.
Kuo JH, Lee JA, Chabot JA. Kuo JH, et al. Surg Clin North Am. 2014 Jun;94(3):689-708. doi: 10.1016/j.suc.2014.02.010. Epub 2014 Apr 13. Surg Clin North Am. 2014. PMID: 24857584 Review.
Pancreatic neuroendocrine tumors are a group of rare, heterogeneous neoplasms that have been increasing in incidence the past few decades largely because of the diagnosis of pancreatic incidentalomas on cross-sectional imaging. Although these tumors are class …
Pancreatic neuroendocrine tumors are a group of rare, heterogeneous neoplasms that have been increasing in incidence the past …
NEN: Advancement in Diagnosis and Minimally Invasive Therapy.
Putzer D, Schullian P, Jaschke W, Bale R. Putzer D, et al. Rofo. 2020 May;192(5):422-430. doi: 10.1055/a-1030-4631. Epub 2019 Nov 20. Rofo. 2020. PMID: 31747704 Free article. Review. English.
Neuroendocrine neoplasms (NEN) are a heterogeneous type of malignant disease and frequently present with symptoms caused by the secretion of metabolically active substances or the manifestation of distant metastases, with the liver being the most frequent site of sp …
Neuroendocrine neoplasms (NEN) are a heterogeneous type of malignant disease and frequently present with symptoms caused by th …
6,359 results